CDK4 and breast carcinoma: The combination of CDK4/6 inhibitors with mTORC1/2 inhibitors has been demonstrated to cause breast cancer cell apoptosis and inhibit Rb (retinoblastoma) phosphorylation and E2F-mediated transcription in CDK4/6 resistant cells [37].